We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00803868
Recruitment Status : Terminated (The DSMB recommended that the study be stopped as a result of concerns regarding safety and intolerability and insufficient evidence of efficacy.)
First Posted : December 8, 2008
Last Update Posted : July 24, 2012
Sponsor:
Collaborators:
Friedreich's Ataxia Research Alliance
Pfizer
Information provided by (Responsible Party):
University of South Florida

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : May 2010
  Study Completion Date : May 2010